🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase III, multicenter, randomized, open-label trial evaluates whether...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-18
Trial ID
NCT07761325
Treatments Being Tested
This is a 12-week, randomized, multicenter, double-blind, placebo controlle...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-02
Trial ID
NCT01000493
Treatments Being Tested
Researchers are looking for new ways to treat esophageal squamous cell carc...
Status
Recruiting
Location
UPMC Hillman Cancer Center ( Site 1904)
Start Date
2025-07-30
Trial ID
NCT06780111
This study is testing whether acupuncture at a point on the wrist called "N...
Status
Enrolling By Invitation
Location
The General Hospital of Western Theater Command
Start Date
2026-07-01
Trial ID
NCT07747194
Treatments Being Tested
The purpose of the study is to determine whether 40 mg aprepitant administe...
Status
Terminated
Location
Mayo Clinic
Start Date
2007-07
Trial ID
NCT00888329
Treatments Being Tested
This is the first study in humans with GSK206136 to evaluate what effects: ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05-23
Trial ID
NCT01059578
This a Phase III trial designed to determine if IV casopitant plus dexameth...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-03-10
Trial ID
NCT00601172
Treatments Being Tested
The objective of this study is to investigate the efficacy of olanzapine as...
Status
Terminated
Location
University of Michigan Rogel Cancer Center
Start Date
2020-12-28
Trial ID
NCT04503668
Treatments Being Tested
Researchers are looking for new ways to treat metastatic nonsquamous non-sm...
Status
Recruiting
Location
University of Kentucky Chandler Medical Center ( Site 0019)
Start Date
2025-05-13
Trial ID
NCT06780085
This study is being conducted to see if adding GW679769 (casopitant) to ZOF...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-03
Trial ID
NCT00326248
Treatments Being Tested